$386.11
0.0% Today
as of Sep 4, 16:46 ET
Last 30 days
Recent Press Releases & News
Bio-Rad (BIO) Up 11.7% Since Last Earnings Report: Can It Continue?
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?
Overview
52-week range
$237
$396
94% of range
Avg surprise (last 2)
+41.0%
Avg reaction (last 1)
-1.5%
0% positive
Latest IV / EM
30%
EM ±4.7% · $390 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $13.85 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-19.55 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-12.70 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $2.61 | $1.93 | +35.2% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $2.54 | $1.73 | +46.8% | — | -1.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $23.34 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-76.26 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $13.45 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $651M | $592M | — | $653M | $652M | $585M | — | $650M |
| Cost of revenue | $305M | $283M | — | $310M | $306M | $279M | — | $294M |
| Gross profit | $346M | $309M | — | $343M | $345M | $306M | — | $356M |
| Operating income | $73M | $34M | — | $65M | $77M | $24M | — | $64M |
| Net income | $371M | $-527M | — | $-342M | $318M | $64M | — | $653M |
| EPS (diluted) | $13.85 | $-19.55 | — | $-12.70 | $11.67 | $2.29 | — | $23.34 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $517M | $507M | $530M | $396M | $369M | $521M | $488M | $410M |
| Inventory | $781M | $770M | $741M | $783M | $799M | $790M | $760M | $804M |
| Total current assets | $3.02B | $2.94B | $2.91B | $2.84B | $2.81B | $3.04B | $3.03B | $3.06B |
| Total assets | $10.25B | $9.79B | $10.58B | $9.70B | $10.21B | $9.53B | $9.36B | $10.60B |
| Long-term debt | $803M | $803M | $1.20B | $1.20B | $1.20B | $1.20B | $1.20B | $1.20B |
| Total liabilities | $3.08B | $2.94B | $3.12B | $2.96B | $3.09B | $2.85B | $2.79B | $3.12B |
| Total equity | $7.17B | $6.85B | $7.45B | $6.74B | $7.13B | $6.68B | $6.57B | $7.49B |